The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Bowman, E. J., Siebers, A., & Altendorf, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7972 · Cited by 1,784
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
NEUVONEN, P., NIEMI, M., & BACKMAN, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.003 · Cited by 859
Obach, R. S., Lombardo, F., & Waters, N. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020479 · Cited by 462
Anderson, N., & Borlak, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.061 · Cited by 346
The potential role of lysosomes in tissue distribution of weak bases
Macintyre, A. C., & Cutler, D. J. (1988) · Biopharmaceutics & Drug Disposition · doi:10.1002/bod.2510090602 · Cited by 208
A high content screening assay for identifying lysosomotropic compounds
Nadanaciva, S., Lu, S., Gebhard, D. F., Jessen, B. A., Pennie, W. D., & Will, Y. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.12.010 · Cited by 203
Drug induced phospholipidosis: An acquired lysosomal storage disorder
Shayman, J. A., & Abe, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.013 · Cited by 152
Cytoplasmic vacuolization during exposure to drugs and other substances
Aki, T., Nara, A., & Uemura, K. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-012-9212-3 · Cited by 137
Funk, R. S., & Krise, J. P. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200641e · Cited by 114
Self-citationMechanisms of Amine Accumulation in, and Egress from, Lysosomes
Goldman, S. D. B., Funk, R. S., Rajewski, R. A., & Krise, J. P. (2009) · Bioanalysis · doi:10.4155/bio.09.128 · Cited by 114
Self-citationPoulin, P., Kenny, J. R., Hop, C. E. C. A., & Haddad, S. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22792 · Cited by 109 · cited 1×
“2) and this slight difference may play a significant role in the disposition of drugs (Berezhkovskiy, 2011; Hallifax and Houston, 2012; Poulin et al., 2012).”
BackgroundPhospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds
Hanumegowda, U., Wenke, G., Regueiro‐Ren, A., Yordanova, R., Corradi, J., & Adams, S. P. (2010) · Chemical Research in Toxicology · doi:10.1021/tx9003825 · Cited by 105
Duvvuri, M., Gong, Y., Chatterji, D., & Krise, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400735200 · Cited by 101
Lemieux, B., Percival, M. D., & Falgueyret, J. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.01.010 · Cited by 98
Hariparsad, N., Carr, B., Evers, R., & Chu, X. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020677 · Cited by 91
Siebert, G. A., Hung, D. Y., Chang, P., & Roberts, M. S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056770 · Cited by 77
Duvvuri, M., & Krise, J. P. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050043s · Cited by 74
Hallifax, D., & Houston, J. B. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015131 · Cited by 72
In Vitro Inhibition and Induction of Human Liver Cytochrome P450 Enzymes by Milnacipran
Paris, B. L., Ogilvie, B. W., Scheinkoenig, J. A., Ndikum-Moffor, F. M., Gibson, R., & Parkinson, A. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028274 · Cited by 69
Self-citationParkinson, A., Kazmi, F., Buckley, D. B., Yerino, P., Paris, B. L., Holsapple, J., Toren, P., Otradovec, S. M., & Ogilvie, B. W. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038596 · Cited by 67
Self-citationBerezhkovskiy, L. M. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22324 · Cited by 63
Kannan, P., Brimacombe, K. R., Kreisl, W. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014641108 · Cited by 63
The Role of Lysosomes in the Cellular Distribution of Thioridazine and Potential Drug Interactions
Daniel, W. A., & Wójcikowski, J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8688 · Cited by 61
Hallifax, D., & Houston, J. B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23202 · Cited by 60
Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data
Muehlbacher, M., Tripal, P., Roas, F., & Kornhuber, J. (2012) · ChemMedChem · doi:10.1002/cmdc.201200306 · Cited by 60
Hallifax, D., & Houston, J. B. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010413 · Cited by 56
Vestal, R. E., Kornhauser, D. M., & Shand, D. G. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32138-5 · Cited by 44
Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications
Logan, R., Funk, R. S., Axcell, E., & Krise, J. P. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.691165 · Cited by 34
Self-citationJigorel, É., & Houston, J. B. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045732 · Cited by 23
Angus, D., Baker, J. Α., Mason, R., & Martin, I. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018879 · Cited by 22
Cited by
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Lysosomes as mediators of drug resistance in cancer
Zhitomirsky, B., & Assaraf, Y. G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.004 · Cited by 482
FGFR-TKI resistance in cancer: current status and perspectives
Yue, S., Li, Y., Chen, X., Wang, J., Li, M., Chen, Y., & Wu, D. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01040-2 · Cited by 145
Lysosomal trapping of palbociclib and its functional implications
Llanos, S., Megias, D., Blanco-Aparicio, C., Hernández-Encinas, E., Rovira, M., Pietrocola, F., & Serrano, M. (2019) · Oncogene · doi:10.1038/s41388-019-0695-8 · Cited by 96
Machine learning models identify molecules active against the Ebola virus in vitro
Ekins, S., Freundlich, J. S., Clark, A. M., Anantpadma, M., Davey, R. A., & Madrid, P. (2015) · F1000Research · doi:10.12688/f1000research.7217.1 · Cited by 84
Metadata
- Authors
- Kazmi, F., Hensley, T., Pope, C., Funk, R. S., Loewen, G. J., Buckley, D. B., & Parkinson, A.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 41
- Issue
- 4
- Pages
- 897-905
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2131582481
- Cited by
- 259
- References
- 32
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.